Success Story: Postdoctoral Research Scholar in Medical Science Achieves NIW Approval without RFE

Client’s Testimonial:

 

"Well organized and detailed."

 


 

On April 24th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Research Scholar in the Field of Medical Science (Approval Notice).

 


 

General Field: Medical Science

 

Position at the Time of Case Filing: Postdoctoral Research Scholar

 

Country of Origin: Bangladesh

 

State at the Time of Filing: California

 

Approval Notice Date: April 24th, 2026

 

Processing Time: 21 months, 5 days

 


 

Case Summary:

 

"His contributions highlight the pathogenesis of complex diseases and emphasize the crucial role of interdisciplinary collaboration in medical research. The benefits of his work are undeniable, offering invaluable insights into the mechanisms underlying neuro-vascular and systemic inflammatory diseases."

 

The statement above is taken from one of two recommendation letters submitted as part of the EB-2 NIW petition. Drawing on our extensive experience and a proven track record of over 32,000 successful cases, our expert team meticulously crafted a compelling petition for an EB-2 NIW (National Interest Waiver) for a postdoctoral research scholar holding a Ph.D. in medical science with advanced expertise in neurovascular biology, neuroinflammation, and the molecular mechanisms underlying neurodevelopmental and mental disorders.

 

Client Background and Proposed Endeavor

 

The client's proposed endeavor is to continue utilizing various scientific techniques in neuroscience and biology to understand how neurovascular mechanisms affect neurodevelopmental and mental disorders, in order to identify new and alternative therapeutic substrates for the treatment of these disorders. With deep expertise in molecular biology, biochemistry, and neurovascular signaling, this researcher's work has direct applications to public health and the well-being of millions of Americans living with these conditions.

 

The researcher has also demonstrated growing recognition within the neuroscience community. In November 2025, the client published a first-authored research paper titled “Selective Vulnerability of GABAergic Neurons in Chronic Migraine,” which was selected for official media coverage through the Society for Neuroscience (SfN) Media Press Conference 2025. This recognition further highlighted the broader scientific and public interest in the client’s work on neurological disorders and disease mechanisms.

 

National Significance of the Research

 

We emphasized that this research is of significant importance and has far-reaching implications for the United States. Neurodevelopmental and mental disorders affect millions of Americans across all age groups, creating an urgent and growing public health need that existing treatment options have yet to fully address. By elucidating the neurovascular underpinnings of these conditions, this researcher's work directly supports the development of novel, evidence-based intervention strategies for a substantial and underserved patient population. The national and international importance of this research is further corroborated by support from a prestigious scientific funding organization, underscoring the broader recognition of its value to the field.

 

Impressive Credentials and Achievements

 

To further strengthen the case, we highlighted exceptional credentials:

 

  • Publications: An impressive portfolio of 5 peer-reviewed journal articles (2 first-authored) and 4 abstracts (1 first-authored)
  • Citations: A total of 52 citations
  • Funding: Research supported by the Japan Society for the Promotion of Science, reflecting international recognition of the research's significance

 

Case Outcome

 

This NIW petition was approved in over 21 months without RFE. We are honored to have supported this researcher throughout the process and look forward to seeing the continued contributions they will make to advancing the understanding of neurodevelopmental and mental disorders in the United States.